Skip to content

S SQUARED TECHNOLOGY, LLC: PSIX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of S SQUARED TECHNOLOGY, LLC on PSIX, newest first. How the timeline and the estimate are built.

S SQUARED TECHNOLOGY, LLC held 0 PSIX shares at 2025-09-30 per its 13F-HR filed 2025-11-14.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -39,574 shares

    13F-HR 0001322924-25-000013 filed by S SQUARED TECHNOLOGY, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-06-30
    13F 39,574 shares
    Change vs previous 13F -123,460 shares

    1.08% of the 13F portfolio, value $2,559,646.

    13F-HR 0001322924-25-000008 filed by S SQUARED TECHNOLOGY, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 163,034 shares
    Change vs previous 13F -130,000 shares

    2.11% of the 13F portfolio, value $4,121,500.

    13F-HR 0001322924-25-000005 filed by S SQUARED TECHNOLOGY, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 293,034 shares
    Change vs previous 13F -206,840 shares

    3.62% of the 13F portfolio, value $8,717,762.

    13F-HR 0001322924-25-000002 filed by S SQUARED TECHNOLOGY, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 499,874 shares
    Change vs previous 13F not available

    4.38% of the 13F portfolio, value $10,272,411.

    13F-HR 0001322924-24-000011 filed by S SQUARED TECHNOLOGY, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).